into the air and inhaled. Stringent quality control since 1976, including separating cosmetic- and food-grade talc from "industrial"-grade talc, has largely eliminated this issue, but it remains a potential hazard requiring mitigation in the mining and processing of talc. A 2010 US FDA survey failed to find asbestos in a variety of talc-containing products. A 2018 Reuters investigation asserted that pharmaceuticals company Johnson & Johnson knew for decades that there was asbestos in its baby powder, and in 2020 the company stopped selling its baby powder in the US and Canada. There were calls for Johnson & Johnson's largest shareholders to force the company to end global sales of baby powder, and hire an independent firm to conduct a racial justice audit as it had been marketed to African American and overweight women. On August 11, 2022, the company announced it would stop making talc-based powder by 2023 and replace it with cornstarch-based powders. The company said the talc-based powder is safe to use and does not contain asbestos. Litigation In 2006 the International Agency for Research on Cancer classified talcum powder as a possible human carcinogen if used in the female genital area. Despite this, no federal agency in the US acted to remove talcum powder from the market or add warnings. In February 2016, as the result of a lawsuit against Johnson & Johnson (J&J), a St. Louis jury awarded $72 million to the family of an Alabama woman who died from ovarian cancer. The family claimed that the use of talcum powder was responsible for her cancer. In May 2016, a South Dakota woman was awarded $55 million as the result of another lawsuit against J&J. The woman had used Johnson & Johnson's Baby Powder for more than 35 years before being diagnosed with ovarian cancer in 2011. In October 2016, a St. Louis jury awarded $70.1 million to a Californian woman with ovarian cancer who had used Johnson's Baby Powder for 45 years. In August 2017, a Los Angeles jury awarded $417 million to a Californian woman, Eva Echeverria, who developed ovarian cancer as a "proximate result of the unreasonably dangerous and defective nature of talcum powder", her lawsuit against Johnson & Johnson stated. On 20 October 2017, Los Angeles Superior Court judge Maren Nelson dismissed the verdict. The judge stated that Echeverria proved there is "an ongoing debate in the scientific and medical community about